Facebook Linkedin RSS Twitter Youtube
Home 2023

Multiple myeloma

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt
Cancer

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt

Thermo Opens Cell Therapy Facility at University of California, San Francisco
Bioprocessing

Thermo Opens Cell Therapy Facility at University of California, San Francisco

Multiple Myeloma Outcomes Linked to Fatty Acid Binding Protein
Cancer

Multiple Myeloma Outcomes Linked to Fatty Acid Binding Protein

Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer
Cancer

Multidrug Nanoparticle Platform Improves Drug Delivery against Cancer

Kite Inks Up-to-$4B Deal to Co-Develop Arcellx Myeloma CAR T-Cell Therapy
News

Kite Inks Up-to-$4B Deal to Co-Develop Arcellx Myeloma CAR T-Cell Therapy

Bispecific Antibody Cancer Treatment Shows 73% Response Rate
Cancer

Bispecific Antibody Cancer Treatment Shows 73% Response Rate

Why Tech Should Answer the Call of Biden’s Bioeconomy Executive Order
Bioprocessing

Why Tech Should Answer the Call of Biden’s Bioeconomy Executive Order

Therapy Options for Multiple Myeloma Patients Who Relapse upon Immunotherapy
Cancer

Therapy Options for Multiple Myeloma Patients Who Relapse upon Immunotherapy

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings
Cancer

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings

CRISPR Gene Editing Critical to Delivering Off-the-Shelf Cell Therapy
Bioprocessing

CRISPR Gene Editing Critical to Delivering Off-the-Shelf Cell Therapy

123...15Page 2 of 15
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.